DIMENSIONAL FUND ADVISORS LP

Position in LENZ — LENZ Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in LENZ

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$383,146

-$1,426,358 QoQ

Shares Held

41,874

-63.0% QoQ

Ownership

0.134%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 57.446147967712655.ToString("F0")% Shared 32.12972250083584.ToString("F0")% None 10.424129531451497.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. LENZ ranks #172 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$383,146	41,874	-63.0%	Shares	Sole	2026-05-07
2025-12-31	$1,809,504	113,094	+176.6%	Shares	Sole	2026-02-12
2025-09-30	$1,904,468	40,886	0.0%	Shares	Sole	2025-11-12
2025-06-30	$1,198,366	40,886	-2.1%	Shares	Sole	2025-08-12
2025-03-31	$1,074,188	41,781	+22.8%	Shares	Sole	2025-05-13
2024-12-31	$982,127	34,019	-0.5%	Shares	Sole	2025-02-13
2024-09-30	$811,265	34,173	-8.1%	Shares	Sole	2024-11-07
2024-06-30	$643,013	37,190	+58.0%	Shares	Sole	2024-08-09
2024-03-31	$525,579	23,537	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.